Business

Bayer to pay $14.2bn for Merck's consumer care division

tablets
Bayer said the deal would boost its sales of over-the counter medicines

German pharmaceuticals firm Bayer has agreed to pay $14.2bn (£8.4bn) to buy US rival Merck's consumer care business.

Bayer said buying the division, which makes Coppertone sun care products, Dr Scholl's foot health and allergy brand Claritin, was "a major milestone".

Bayer said Merck would separately pay it $1bn in a co-development deal over heart failure drugs.

It said the deal would help it develop sales outside the US.

Bayer also expects to become the second largest player in non-prescription, over-the-counter products as a result of the acquisition.

"With this transaction, we are acquiring leading product brands," said Bayer HealthCare boss Olivier Brandicourt.

Bayer said it expected the integration of the two businesses to generate significant cost savings of around $200m per year by 2017.

It said increasing its commercial presence and rolling out Merck's brands globally would amount to an additional $400m in revenues per year by 2017.

More on this story

Related Internet links

The BBC is not responsible for the content of external Internet sites